NOTE (NOTE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Q4 performance aligned with December guidance, with notable fluctuations in the final weeks.
Net sales for 2024 were SEK 3,901 million, down 8% from SEK 4,243 million in 2023; organic growth was -10% year-over-year, reflecting a temporary sector slowdown and customer inventory adjustments.
Underlying profitability in Q4 was the second-best ever, with an adjusted operating margin of 10.5%.
Operating cash flow after investments reached SEK 465 million, with a strong cash position and balance sheet.
The board will decide on dividends or share buybacks for 2024 at the latest in connection with the 2025 AGM notice.
Financial highlights
Q4 2024 sales were SEK 1,025 million (Q4 2023: SEK 1,080 million); organic growth -6% year-over-year.
Full-year sales down 8% (10% excluding acquisitions), but margins held steady.
Q4 adjusted operating margin was 10.5% (Q4 2023: 8.5%), the second highest ever reported.
Gross margin for 2024 was 13.3% (2023: 12.1%); Q4 gross margin was 14.5% (Q4 2023: 9.7%).
Equity ratio reached 51%, the highest level in recent history.
Outlook and guidance
Q1 2025 sales expected to be similar to Q4 2024, with slightly higher volumes but lower component prices.
Full-year 2025 sales guidance: SEK 3.9–4.3 billion, with steeper growth expected in the second half.
Profitability guidance for 2025: 9.5%–10.5% margin, with potential upside if volumes recover.
Order backlog for 2025 is down 2% year-over-year, reflecting cautious market sentiment.
Strong cash flow expected to continue in the first half of the year due to ongoing inventory reductions.
Latest events from NOTE
- Sales and profit fell, but margins and cash flow improved as investments support future growth.NOTE
Q2 20243 Feb 2026 - Record Q4 profitability and strategic acquisitions drive growth despite market softness.NOTE
Q4 20252 Feb 2026 - Sales fell 22% in Q3, but strong cash flow and expansion plans support future growth.NOTE
Q3 202419 Jan 2026 - Double-digit profitability and stable growth expected, with defense and medtech leading future gains.NOTE
CMD 202411 Jan 2026 - Profitability and cash flow hit highs, with Security & Defence and Greentech driving growth.NOTE
Q1 202523 Dec 2025 - Strong Q2 sales and cash flow, with H2 growth expected despite FX and market headwinds.NOTE
Q2 202516 Nov 2025 - Q3 2025 saw strong growth, profitability, and a strategic UK acquisition for future expansion.NOTE
Q3 202520 Oct 2025